Immunodeficient NSG mice transplanted with D115 human T-ALL PDX cells (activating Notch1 mutations) were treated with ARV-825 (10 mg/kg intraperitoneally three times a week) or a vehicle on day 8 after confirmation of disease establishment (Fig. 4D upper panel). This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.